Formation of covalently bound protein adducts from the cytotoxicant naphthalene in nasal epithelium: Species comparisons

Environmental Health Perspectives

Volumn 118, Issue 5, 2010, Pages 647-652

  DeStefano Shields, Christina ^a,b   Morin, Dexter ^a   Buckpitt, Alan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Monkey; Naphthalene; Nasal epithelium; Protein adducts; Rat; Reactive metabolites; Species comparisons

Indexed keywords

ACTIN; NAPHTHALENE; TUBULIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COVALENT BOND; DISEASE MARKER; FEMALE; LUNG TOXICITY; MACACA; MALE; MOUSE; NONHUMAN; NOSE MUCOSA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SPECIES COMPARISON; TOXICOKINETICS; TURBINATE;

ANIMALS; DISEASE MODELS, ANIMAL; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; LUNG DISEASES; MACACA MULATTA; MALE; MICE; NAPHTHALENES; NASAL MUCOSA; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY;

MACACA MULATTA; MURINAE; MUS; RATTUS; RODENTIA;

EID: 77951754710     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0901333     Document Type: Article

References (52)

1. Abdo K, Eustis S, McDonald M, Joiken M, Adkins B, Haseman J. 1992. Naphthalene: a respiratory tract toxicant and carcinogen for mice. Inhal Toxicol 4:393-409.
2. Abdo K, Grumbein S, Chou BJ, Herbert R. 2001. Toxicity and carcinogenicity study in F344 rats following 2 years of whole-body exposure to naphthalene vapors. Inhal Toxicol 13:931-950.
3. Al-Daghri NM. 2008. Serum polycyclic aromatic hydrocarbons among children with and without asthma: correlation to environmental and dietary factors. Int J Occup Med Environ Health 21:211-217.
4. Baldwin RM, Shultz MA, Buckpitt AR. 2005. Bioactivation of the pulmonary toxicants naphthalene and 1-nitronaphthalene by rat CYP2F4. J Pharmacol Exp Ther 312:857-865.
5. Boland B, Lin CY, Morin D, Miller L, Plopper CG, Buckpitt A. 2004. Site specific metabolism of naphthalene and 1-nitronaphthalene in dissected airways of rhesus macaques. J Pharmacol Exp Ther 310:546-554.
6. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
7. Brodie BB, Reid WD, Cho AK, Sipes G, Krishna G, Gillette JR. 1971. Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc Natl Acad Sci USA 68:160-164.
8. Brusick D. 2008. Critical assessment of the genetic toxicity of naphthalene. Regul Toxicol Pharmacol 51:S37-S42.
9. Buckpitt A, Bahnson L. 1986. Naphthalene metabolism by human lung microsomal enzymes. Toxicology 41:333-341.
10. Buckpitt A, Boland B, Isbell M, Morin D, Shultz M, Baldwin R, et al. 2002. Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metab Rev 34:791-820.
11. Buckpitt A, Buonarati M, Avey LB, Chang AM, Morin D, Plopper CG. 1992. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey. J Pharmacol Exp Ther 261:364-372.
12. Buckpitt A, Chang AM, Weir A, Van Winkle L, Duan X, Philpot R, et al. 1995. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters. Mol Pharmacol 47:74-81.
13. Chen FC, Ogut O. 2006. Decline of contractility during ischemia-reperfusion injury: actin glutathionylation and its effect on allosteric interaction with tropomyosin. Am J Physiol Cell Physiol 290:C719-C727.
14. Cho M, Chichester C, Morin D, Plopper C, Buckpitt A. 1994. Covalent interactions of reactive naphthalene metabolites with proteins. J Pharmacol Exp Ther 269:881-889.
15. Cho TM, Rose RL, Hodgson E. 2006. In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes. Drug Metab Dispos 34:176-183.
16. 374 regulates actin filament formation by inducing structural changes in the actin molecule. Free Radic Biol Med 34:23-32.
17. Dennehy MK, Richards KA, Wernke GR, Shyr Y, Liebler DC. 2006. Cytosolic and nuclear protein targets of thiol-reactive electrophiles. Chem Res Toxicol 19:20-29.
18. Ding X, Kaminsky LS. 2003. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149-173.
19. Dodd DE, Gross EA, Miller RA, Wong BA. 2010. Nasal olfactory epithelial lesions in F344 and SD rats following 1- and 5-day inhalation exposure to naphthalene vapor. Int J Toxicol 29(2):175-184.
20. Fang J, Koen Y, Hanzlik R. 2009. Bioinformatic analysis of xenobiotic reactive metabolite target proteins and their interacting partners. BMC Chemical Biology 9:5; doi:10.1186/1472-6769-9-5 [Online 12 June 2009].
21. Fukami T, Katoh M, Yamazaki H, Yokoi T, Nakajima M. 2008. Human cytochrome p450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene, styrene, and toluene. Chem Res Toxicol 21:720-725.
22. Green T, Toghill A, Foster JR. 2001. The role of cytochromes P-450 in styrene induced pulmonary toxicity and carcinogenicity. Toxicology 169:107-117.
23. Hanzlik RP, Fang J, Koen YM. 2009. Filling and mining the reactive metabolite target protein database. Chem Biol Interact 179:38-44.
24. Ikehata K, Duzhak TG, Galeva NA, Ji T, Koen YM, Hanzlik RP. 2008. Protein targets of reactive metabolites of thiobenzamide in rat liver in vivo. Chem Res Toxicol 21:1432-1442.
25. International Agency for Research on Cancer. 2002. Naphthalene. IARC Monogr Eval Carcinog Risks Hum 82:367-436.
26. Kelsen SG, Duan X, Ji R, Perez O, Liu C, Merali S. 2008. Cigarette smoke induces an unfolded protein response in the human lung: a proteomic approach. Am J Respir Cell Mol Biol 38:541-550.
27. Kim JH, Kim JK, Son BK, Oh JE, Lim DH, Lee KH, et al. 2005. Effects of air pollutants on childhood asthma. Yonsei Med J 46:239-244.
28. Lanza DL, Code E, Crespi CL, Gonzalez FJ, Yost GS. 1999. Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells. Drug Metab Dispos 27:798-803.
29. Lee MG, Phimister A, Morin D, Buckpitt A, Plopper C. 2005. In situ naphthalene bioactivation and nasal airflow cause region-specific injury patterns in the nasal mucosa of rats exposed to naphthalene by inhalation. J Pharmacol Exp Ther 314:103-110.
30. Li Z, Sandau CD, Romanoff LC, Caudill SP, Sjodin A, Needham LL, et al. 2008. Concentration and profile of 22 urinary polycyclic aromatic hydrocarbon metabolites in the US population. Environ Res 107:320-331.
31. Lin CY, Boland BC, Lee YJ, Salemi MR, Morin D, Miller LA, et al. 2006. Identification of proteins adducted by reactive metabolites of naphthalene and 1-nitronaphthalene in dissected airways of rhesus macaques. Proteomics 6:972-982.
32. Lin CY, Isbell MA, Morin D, Boland BC, Salemi MR, Jewell WT, et al. 2005. Characterization of a structurally intact in situ lung model and comparison of naphthalene protein adducts generated in this model vs lung microsomes. Chem Res Toxicol 18:802-813.
33. Long PH, Herbert RA, Peckham JC, Grumbein SL, Shackelford CC, Abdo K. 2003. Morphology of nasal lesions in F344/N rats following chronic inhalation exposure to naphthalene vapors. Toxicol Pathol 31:655-664.
34. Lu R, Wu J, Turco RP, Winer AM, Atkinson R, Arey J, et al. 2005. Naphthalene distributions and human exposure in Southern California. Atmos Environ 39:489-507.
35. Meier BW, Gomez JD, Kirichenko OV, Thompson JA. 2007. Mechanistic basis for inflammation and tumor promotion in lungs of 2,6-di-tert-butyl-4-methylphenol-treated mice: electrophilic metabolites alkylate and inactivate antioxidant enzymes. Chem Res Toxicol 20:99-107.
36. Meier BW, Gomez JD, Zhou A, Thompson JA. 2005. Immunochemical and proteomic analysis of covalent adducts formed by quinone methide tumor promoters in mouse lung epithelial cell lines. Chem Res Toxicol 18:1575-1585.
37. National Toxicology Program. 2004. Naphthalene, CAS No. 91-20-3. In: Report on Carcinogens, Eleventh Edition. Available: http://ntp.niehs.nih.gov/ntp/roc/eleventh/profiles/s116znph.pdf [accessed 12 August 2009].
38. Nhamburo PT, Kimura S, McBride OW, Kozak CA, Gelboin HV, Gonzalez FJ. 1990. The human CYP2F gene subfamily: identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression, and chromosome mapping. Biochemistry 29:5491-5499.
39. North DW, Abdo KM, Benson JM, Dahl AR, Morris JB, Renne R, et al. 2008. A review of whole animal bioassays of the carcinogenic potential of naphthalene. Regul Toxicol Pharmacol 51:S6-S14.
40. Odum J, Foster JR, Green T. 1992. A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene. Chem Biol Interact 83:135-153.
41. Phimister AJ, Williams KJ, Van Winkle LS, Plopper CG. 2005. Consequences of abrupt glutathione depletion in murine Clara cells: ultrastructural and biochemical investigations into the role of glutathione loss in naphthalene cytotoxicity. J Pharmacol Exp Ther 314:506-513.
42. Plopper CG, Chang A, Pang A, Buckpitt A. 1991. Use of microdissected airways to better define metabolism and cytotoxicity in murine bronchiolar epithelium. Exp Lung Res 17:181-196.
43. Plopper CG, Macklin J, Nishio S, Hyde D, Buckpitt A. 1992. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. III. Morphometric comparison of changes in the epithelial populations of terminal bronchioles and lobar bronchi in mice, hamsters and rats after parenteral administration of naphthalene. Lab Invest 67:553-565.
44. Saeed M, Higginbotham S, Gaikwad N, Chakravarti D, Rogan E, Cavalieri E. 2009 Depurinating naphthalene-DNA adducts in mouse skin related to cancer initiation. Free Radic Biol Med 47:1075-1081.
45. Saeed M, Higginbotham S, Rogan E, Cavalieri E. 2007. Formation of depurinating N3adenine and N7guanine adducts after reaction of 1,2-naphthoquinone or enzyme-activated 1,2-dihydroxynaphthalene with DNA. Implications for the mechanism of tumor initiation by naphthalene. Chem Biol Interact 165:175-188.
46. Salam MT, Lin PC, Avol EL, Gauderman WJ, Gilliland FD. 2007. Microsomal epoxide hydrolase, glutathione S-transferase P1, traffic and childhood asthma. Thorax 62:1050-1057.
47. Shultz MA, Choudary PV, Buckpitt AR. 1999. Role of murine cytochrome P-450 2F2 in metabolic activation of naphthalene and metabolism of other xenobiotics. J Pharmacol Exp Ther 290:281-288.
48. Townsend DM. 2007. S-Glutathionylation: indicator of cell stress and regulator of the unfolded protein response. Mol Interv 7:313-324.
49. Van Winkle L, Johnson Z, Nishio S, Brown C, Plopper CG. 1999. Early events in naphthalene-induced acute Clara cell toxicity. Comparison of membrane permeability and ultrastructure. Am J Respir Cell Mol Biol 21:44-53.
50. West J, Pakenham G, Morin D, Fleschner C, Buckpitt A, Plopper C. 2001. Inhaled naphthalene causes dose dependent Clara cell toxicity in mice but not in rats. Toxicol Appl Pharmacol 173:114-119.
51. Williams KE, Carver TA, Miranda JJ, Kautiainen A, Vogel JS, Dingley K, et al. 2002. Attomole detection of in vivo protein targets of benzene in mice: evidence for a highly reactive metabolite. Mol Cell Proteomics 1:885-895.
52. Williams KJ, Cruikshank MK, Plopper CG. 2003. Pulmonary heat shock protein expression after exposure to a metabolically activated Clara cell toxicant: relationship to protein adduct formation. Toxicol Appl Pharmacol 192:107-118.